From: medicalxpress.com Women of African ancestry more often have a personal history of triple-negative breast cancer (TNBC), but the magnitudes of gene-specific risks for TNBC are similar across different racial/ethnic groups, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held from June 3 to 7 in Chicago. Michael J. Hall, M.D., from …
Caris Life Sciences Introduces the Caris Assure™ Liquid Biopsy Assay at ASCO 2022
Caris Assure is the most powerful liquid biopsy assay ever developed, providing whole exome and whole transcriptome sequencing (WES/WTS) assessing somatic tumor, somatic CHIP and germline alterations Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today introduced its Caris Assure™ liquid biopsy assay at the 2022 American Society of …
Factors of Therapy Delivery Tied to Adherence in Nonmetastatic Breast Cancer
By: Conference Insider From: oncnet.com The method by which adjuvant endocrine therapy is delivered to patients with breast cancer is associated with rate of adherence, according to data being presented by Joan Marie Neuner, MD, MPH, Medical College of Wisconsin, Milwaukee, and colleagues at the virtual 2020 ASCO Annual Meeting. “Over 50% of breast cancer patients prescribed adjuvant endocrine therapy…are …